학술논문

Gamma-oryzanol alleviates osteoarthritis development by targeting Keap1–Nrf2 binding to interfere with chondrocyte ferroptosis
Document Type
Article
Source
In: International Immunopharmacology. (International Immunopharmacology, 15 February 2024, 128)
Subject
Language
English
ISSN
18781705
15675769